- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
AAV ProDUCTS & SERVICE
AAV TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
AAV-Retro(Retrograde) Rep-Cap plasmid (retrograde transport validated serotype AAV RC plamid) (Amp and Kanamycin) (GeneMedi Owned)
GeneMedi's AAV-Retro (Retrograde) Rep-Cap plasmid supplies the AAV2 Rep (replication) proteins and the AAV-Retro (Retrograde) capsid protein.
You can produce AAV-Retro (Retrograde) particle in 293T cell line in high titer using GeneMedi's AAV-Retro (Retrograde) Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
The tissue tropism of AAV2-Retro (Retrograde) vector has been validated in robust retrograde transport in the brain.The AAV2-Retro is a powerful tool for neuron signal tracing in the brain and in CNS instead of infective pseudorabies virus (PRV) or Canine adenovirus (CAV).
GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids.
Go to AAV
vector system
>>
Manual
Product Description
| Cat.NO | Product Name | Organization Type | Price(In USD) | ||
|---|---|---|---|---|---|
| P-RC17 | AAV-Retro (Retrograde) Rep-Cap Plasmid (Amp resistance) Size：5ug | Academic | 1719 | ||
| P-RC17 | AAV-Retro (Retrograde) Rep-Cap Plasmid (Amp resistance) Size：5ug | Industry R&D (excluding CRO&CDMO&CXO) |
|||
| P-RC17 | AAV-Retro (Retrograde) Rep-Cap Plasmid (Amp resistance) Size：5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-RC17 | AAV-Retro (Retrograde) Rep-Cap Plasmid (Amp resistance) Size：≥10mg |
All | |||
| P-RC17-Kan | AAV-Retro (Retrograde) Rep-Cap Plasmid (Kan resistance) Size：≥10mg |
All | |||
| P-PK17 | AAV-Retro (Retrograde) Vector
System (Amp resistance)
1. AAV-Retro (Retrograde) Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug |
Academic | 3024 | ||
| P-PK17 | AAV-Retro (Retrograde) Vector
System (Amp resistance)
1. AAV-Retro (Retrograde) Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Industry R&D (excluding CRO&CDMO&CXO) |
|||
| P-PK17 | AAV-Retro (Retrograde) Vector
System (Amp resistance)
1. AAV-Retro (Retrograde) Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-PK17 | AAV-Retro (Retrograde) Vector
System (Amp resistance)
1. AAV-Retro (Retrograde) Rep-Cap Plasmid, ≥10mg 2. AAV Helper Plasmid, ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-PK17-Kan | AAV-Retro (Retrograde) Vector
System(Kan resistance)
1. AAV-Retro (Retrograde) Rep-Cap Plasmid(Kan resistance), ≥10mg 2. AAV Helper Plasmid(Kan resistance), ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg |
All | |||
|
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Rep-Cap Plasmid. GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Rep-Cap Plasmid currently. |
|||||
| If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
|
Terms of sale: For Seed (5ug): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party. For plasmid production& amplification (≥10mg): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party. |
|||||
Citation
| Title | Publication | Date |
|---|---|---|
| T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy | Nature Nanotechnology | 2021/9/27 |
| Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis | Molecular Cancer | 2022/3/10 |
| TMEM215 Prevents Endothelial Cell Apoptosis in Vessel Regression by Blunting BIK-Regulated ER-to-Mitochondrial Ca Influx | Circulation Research | 2023/10/13 |
| Retinol dehydrogenase 10 reduction mediated retinol metabolism disorder promotes diabetic cardiomyopathy in male mice | Nature Communications | 2023/3/2 |
| High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein | Nucleic Acids Research | 2022/2/7 |
| Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation | Mol Cancer | 2020/6/1 |
| Engineering cannabidiol synergistic carbon monoxide nanocomplexes to enhance cancer therapy via excessive autophagy | Acta Pharmaceutica Sinica B | 2023/5/29 |
| Syntaxin17 contributes to obesity cardiomyopathy through promoting mitochondrial Ca2+ overload in a Parkin-MCUb-dependent manner | METABOLISM-CLINICAL AND EXPERIMENTAL | 2023/3/20 |
| CKLF induces microglial activation via triggering defective mitophagy and mitochondrial dysfunction | Autophagy | 2023/10/31 |
| FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism | Cell Death & Differentiation | 2024/2/19 |
Validation data
No data found
Associated products and services
| Products & Service | Products & Service Information |
|---|---|
| AAV Packaging service | Detail |
| Promise-ORF™ viral CDNA library | Detail |
| Plasmid DNA Rapid Preparation Service | Detail |
Facebook
LinkedIn
Twitter
